Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Caplin

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Neuroendocrinology|March 25, 2009
Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapiesR Srirajaskanthan, J Watkins, L Marelli, et al.
Cancer Research|November 4, 2000
Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumorS A Watson, P A Clarke, T M Morris, et al.
Oncology Reports|September 6, 2005
CCK2 gastrin receptor as a potential target for therapy in leukaemia cell linesM Stubbs, K Khan, R G Wickremasinghe, et al.
Alimentary Pharmacology & Therapeutics|May 19, 2011
Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)M S Khan, F El-Khouly, P Davies, et al.
Endocrine-Related Cancer|June 9, 2009
Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosisR Srirajaskanthan, G Dancey, A Hackshaw, et al.
Journal of Neuroendocrinology|April 25, 2006
Epidermal growth factor receptor expression and activation in neuroendocrine tumoursT Shah, D Hochhauser, R Frow, et al.
British Journal of Cancer|April 13, 2013
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasmsM S Khan, T V Luong, J Watkins, et al.
Alimentary Pharmacology & Therapeutics|July 4, 2009
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LARC Toumpanakis, J Garland, L Marelli, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine featuresJ B Cwikła, J R Buscombe, W A Mielcarek, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2008
Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patientsR Srirajaskanthan, C Toumpanakis, A Karpathakis, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Neuroendocrinology|March 25, 2009
Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapiesR Srirajaskanthan, J Watkins, L Marelli, et al.
Cancer Research|November 4, 2000
Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumorS A Watson, P A Clarke, T M Morris, et al.
Oncology Reports|September 6, 2005
CCK2 gastrin receptor as a potential target for therapy in leukaemia cell linesM Stubbs, K Khan, R G Wickremasinghe, et al.
Alimentary Pharmacology & Therapeutics|May 19, 2011
Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel)M S Khan, F El-Khouly, P Davies, et al.
Endocrine-Related Cancer|June 9, 2009
Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosisR Srirajaskanthan, G Dancey, A Hackshaw, et al.
Journal of Neuroendocrinology|April 25, 2006
Epidermal growth factor receptor expression and activation in neuroendocrine tumoursT Shah, D Hochhauser, R Frow, et al.
British Journal of Cancer|April 13, 2013
A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasmsM S Khan, T V Luong, J Watkins, et al.
Alimentary Pharmacology & Therapeutics|July 4, 2009
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LARC Toumpanakis, J Garland, L Marelli, et al.
Nuclear Medicine Review. Central & Eastern Europe|November 6, 2003
Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine featuresJ B Cwikła, J R Buscombe, W A Mielcarek, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2008
Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patientsR Srirajaskanthan, C Toumpanakis, A Karpathakis, et al.
Pageof 4